Nanjing Well Pharmaceutical Co Ltd (603351) — Cash Flow Quality Index
Nanjing Well Pharmaceutical Co Ltd (603351) has a Cash Flow Quality Index of 1.68x as of September 2025. Operating cash flow of CN¥69.51 Million exceeds net income of CN¥41.30 Million, indicating high earnings quality where cash backs reported profits. Explore Nanjing Well Pharmaceutical Co Ltd cash conversion from operations to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Nanjing Well Pharmaceutical Co Ltd Cash Flow Quality Index (2014–2024)
Historical Cash Flow Quality Index for Nanjing Well Pharmaceutical Co Ltd across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check total reinvestment intensity of Nanjing Well Pharmaceutical Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Nanjing Well Pharmaceutical Co Ltd (2014–2024)
Year-by-year earnings quality comparison for Nanjing Well Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see Nanjing Well Pharmaceutical Co Ltd (603351) total market value.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.53x | CN¥221.79 Million | CN¥145.21 Million | ▲ +38.6% |
| 2023 | 1.10x | CN¥120.24 Million | CN¥109.11 Million | ▼ -4.5% |
| 2022 | 1.15x | CN¥108.99 Million | CN¥94.43 Million | ▲ +1101.9% |
| 2021 | -0.12x | CN¥-11.54 Million | CN¥100.15 Million | ▼ -112.4% |
| 2020 | 0.93x | CN¥93.30 Million | CN¥100.45 Million | ▼ -8.2% |
| 2019 | 1.01x | CN¥129.69 Million | CN¥128.11 Million | ▲ +77.5% |
| 2018 | 0.57x | CN¥63.76 Million | CN¥111.81 Million | ▼ -14.0% |
| 2017 | 0.66x | CN¥71.27 Million | CN¥107.44 Million | ▼ -61.9% |
| 2016 | 1.74x | CN¥128.18 Million | CN¥73.71 Million | ▲ +30.2% |
| 2015 | 1.34x | CN¥81.14 Million | CN¥60.73 Million | ▼ -19.7% |
| 2014 | 1.66x | CN¥74.62 Million | CN¥44.83 Million | — |